Our study has shown that (i) no serious risks for health exist for psoriasis patients willing to fast, (ii) fasting has a beneficial effect in terms of PASI score reduction, and (iii) this effect was particularly evident in patients treated with apremilast or mTOR inhibitors. Here, MTOR is linked to psoriasis.